ArticleScientific reports2025
Hybrid classical and quantum computing for enhanced glioma tumor classification using TCGA data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Biomarker identification of triple negative breast cancer subtypes using machine learning.NPJ systems biology and applications · 2026Article
- From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy Selection.International journal of molecular sciences · 2026Review
- Mapping EEG Metrics to Human Affective and Cognitive Models: An Interdisciplinary Scoping Review from a Cognitive Neuroscience Perspective.Biomimetics (Basel, Switzerland) · 2025Review
- Customized SAM-Med3D with multi-view adapter and T2-FLAIR mismatch features for glioma IDH genotyping and grading.Frontiers in behavioral neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Gliomas are the most prevalent malignant primary brain tumors and present diagnostic challenges due to varying survival rates and treatment responses between low-grade gliomas (LGGs) and high-grade gliomas (HGGs). Accurate classification is crucial for effective treatment and prognosis. While classical AI methods have shown promise in glioma classification, the growing volume of medical data, inherent noise, and limitations of classical vector spaces present significant challenges. However, quantum computing-based AI methods have the potential to process data in parallel by leveraging quantum properties such as superposition and entanglement, analyze higher-dimensional data more efficiently, and solve certain problems that classical methods struggle with more rapidly and effectively. This study introduces a novel hybrid classical and quantum computing model to distinguish LGGs from HGGs using data from The Cancer Genome Atlas (TCGA). In the classical part, an ensemble feature selection method was employed to identify the most informative molecular markers and clinical features in the TCGA. In the quantum component, six variational quantum classifier (VQC) models with varying hyperparameters were evaluated. These classifiers utilize selected features to differentiate LGGs from HGGs. Among these, the VQC-1 model, which employs [Formula: see text] and CX gates in the feature map and [Formula: see text] [Formula: see text] and CY gates in the parameterized quantum circuit, achieved the highest classification accuracy of 0.74 using the AQCD optimization method. Additionally, VQC-1 identified IDH1, age at diagnosis, PTEN, EGFR, and ATRX, in descending order of importance, as the most informative features distinguishing LGGs from HGGs. Compared to classical machine learning models, VQC-1 demonstrated performance comparable to that of XGBoost and GBM, while outperformed KNN, SVC, DTC, and RFC in five-fold cross-validation experiments. This study provides a novel perspective on glioma classification by integrating classical and quantum computing, offering valuable insights into hybrid computational approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.